scPharmaceuticals Inc. (SCPH)
Largest Insider Buys in Sector
SCPH Stock Price History Chart
SCPH Stock Performance
About scPharmaceuticals Inc.
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by …
Insider Activity of scPharmaceuticals Inc.
Over the last 12 months, insiders at scPharmaceuticals Inc. have bought $2M and sold $0 worth of scPharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at scPharmaceuticals Inc. have bought $6.33M and sold $2.34M worth of stock each year.
Highest buying activity among insiders over the last 12 months: ORBIMED ADVISORS LLC (10 percent owner) — $70M.
The last purchase of 500,000 shares for transaction amount of $2M was made by ORBIMED ADVISORS LLC (10 percent owner) on 2024‑08‑13.
List of Insider Buy and Sell Transactions, scPharmaceuticals Inc.
| 2024-08-13 | 10 percent owner | 500,000 1.2438% | $4.00 | $2M | 0.00% | |||
| 2022-11-25 | director | 762,380 1.7007% | $5.25 | $4M | +1.99% | |||
| 2022-10-10 | Sale | director | 562,466 1.831% | $4.09 | $2.3M | +91.04% | ||
| 2022-10-06 | Sale | director | 37,534 0.1225% | $5.02 | $188,421 | +56.10% | ||
| 2022-09-06 | Sale | 6,793 0.022% | $4.75 | $32,267 | +43.28% | |||
| 2022-04-11 | Sale | 220,096 0.776% | $5.00 | $1.1M | +10.62% | |||
| 2021-12-03 | President and CEO | 10,000 0.0373% | $3.96 | $39,553 | +30.15% | |||
| 2021-12-03 | director | 5,000 0.0184% | $3.91 | $19,569 | +30.15% | |||
| 2021-03-15 | Sale | 10 percent owner | 110,588 0.3963% | $7.03 | $777,788 | -20.33% | ||
| 2021-03-12 | Sale | 10 percent owner | 39,469 0.1461% | $7.22 | $284,816 | -19.78% | ||
| 2020-05-26 | 10 percent owner | 578,034 2.5395% | $8.65 | $5M | -12.34% | |||
| 2020-05-21 | 10 percent owner | 1.39M 6.0411% | $8.65 | $12M | -12.99% | |||
| 2020-02-14 | 10 percent owner | 271,993 1.2768% | $8.20 | $2.23M | -7.06% | |||
| 2019-12-13 | President and CEO | 5,000 0.0266% | $5.24 | $26,189 | +52.26% | |||
| 2019-04-11 | 10 percent owner | 389,862 2.1623% | $2.70 | $1.05M | +109.92% | |||
| 2017-11-21 | 10 percent owner | 833,333 9.7286% | $14.00 | $11.67M | -28.96% | |||
| 2017-11-21 | 10 percent owner | 1.31M 15.2879% | $14.00 | $18.33M | -28.96% | |||
| 2017-11-21 | 1.31M 15.2879% | $14.00 | $18.33M | -28.96% | ||||
| 2017-11-21 | 10 percent owner | 1.31M 7.6439% | $7.00 | $9.17M | -28.96% | |||
| 2017-11-21 | 10 percent owner | 714,286 8.3388% | $14.00 | $10M | -28.96% |
Insider Historical Profitability
| ORBIMED ADVISORS LLC | 10 percent owner | 5806670 11.6067% | $4.31 | 4 | 0 | <0.0001% |
| Lundbeckfond Invest A/S | 10 percent owner | 3183986 6.3643% | $4.31 | 1 | 0 | <0.0001% |
| Agger Mette Kirstine | 3183986 6.3643% | $4.31 | 1 | 0 | <0.0001% | |
| 5AM Partners IV, LLC | 10 percent owner | 3123302 6.243% | $4.31 | 1 | 0 | <0.0001% |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 2727446 5.4518% | $4.31 | 2 | 2 | +51.43% |
Institutional Investor Ownership
| OrbiMed | $27.91M | 15.42 | 5.56M | 0% | +$0 | 0.22 | |
| Helm Capital Management LLC | $17.7M | 9.78 | 3.52M | +0.71% | +$125,500.00 | 0.52 | |
| Aigh Capital Management Llc | $17.01M | 9.4 | 3.39M | +9.09% | +$1.42M | 9.73 | |
| BlackRock | $9.04M | 5 | 1.8M | -3.32% | -$310,381.57 | <0.0001 | |
| Luther King Capital Management | $7.29M | 4.03 | 1.45M | +4.28% | +$299,242.21 | 0.03 |